Laura Trutoiu, Ph.D. Joins Association for Creatine Deficiencies as Director of Research

CARLSBAD, Calif., July 11, 2018 (Newswire.com) - The Association for Creatine Deficiencies (ACD) is pleased to welcome Laura Trutoiu, Ph.D., as its newest member of the Board of Trustees. Laura will step into the role of Director of Research and will support ACD’s research initiatives including grant writing, patient registry coordination, establishing and reviewing a Cerebral Creatine Deficiency Syndromes (CCDS) medical journal library, and collaborating with leading CCDS experts to drive interest and research for creatine deficiencies.

Laura holds a Ph.D. from the Robotics Institute at Carnegie Mellon University and a BA in Computer Science from Mount Holyoke College. She has conducted research in several industry labs including Disney Research, Industrial Light and Magic, Oculus Research & Facebook, and currently Magic Leap. Her research spans computer graphics, human perception, and sensing and interaction for virtual and mixed reality systems. “I am passionate about stepping into this role and supporting the potential for CCDS scientific discovery to help serve this rare disease community,” said Laura.

I am passionate about stepping into this role and supporting the potential for CCDS scientific discovery to help serve this rare disease community.

Laura Trutoiu, Ph.D., ACD Director of Research

The ACD is committed to the pursuit of new and more efficient treatment options for GAMT, AGAT, and CTD patients. “The addition of Dr. Trutoiu brings much-needed value to the ACD,” commented President, Whitnie Strauss. “Supporting, funding, and initiating research are top priorities, and we are excited to be able to increase these efforts by bringing on a research-focused director within our leadership,” said Strauss.

About ACD: The Association for Creatine Deficiencies’ mission is to eliminate the challenges of CCDS. ACD is committed to providing patient, family, and public education to advocate for early intervention through newborn screening, and to promote and fund medical research for treatments and cures for Cerebral Creatine Deficiency Syndromes. Because CCDS mimic symptoms of other medical conditions, patients are often first diagnosed with autism, cerebral palsy, epilepsy, and other disorders. Proper diagnosis and early intervention are critical to establishing screening and treatments needed to improve life quality and longevity for the CCDS patient. For more information regarding ACD, please visit http://www.creatineinfo.org. 

Source: Association for Creatine Deficiencies